WaveMan
WaveMan · Company
ECBK · Ecb Bancorp, Inc. /Md/
> Search tickers & screens ⌘K
LIVE
← All companies

ECBK ECB Bancorp (ECBK) Insider Trading, Ownership & Congress Trades

Banks · Savings institutions, not federally chartered · CIK 0001914605
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
33
13F, latest reported quarter

ECB Bancorp insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for ECB Bancorp, Inc. /MD/ in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
BUY
2026-05-01 SECtraded 2026-04-30
10
$179
+17.2%
Context
  • 45 earlier Form 4 trades (code P or S) here by this insider (45 buys), the last on Feb 24, 2025.
  • +12.2% median (+10.9% mean) 90-day return after 4 previous buys.
  • The trade is 0.0% of the 32,403 shares held after it.
  • No other insider bought within 30 days.
  • 33 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CFO Lavertu Brandon bought about $179 of ECBK on Apr 30, 2026; 33 funds added in the latest 13F quarter.
BUY
2026-05-01 SECtraded 2026-04-30
10
$179
+17.2%
Context
  • 45 earlier Form 4 trades (code P or S) here by this insider (45 buys), the last on Feb 24, 2025.
  • +12.2% median (+10.9% mean) 90-day return after 4 previous buys.
  • The trade is 0.0% of the 32,413 shares held after it.
  • No other insider bought within 30 days.
  • 33 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CFO Lavertu Brandon bought about $179 of ECBK on Apr 30, 2026; 33 funds added in the latest 13F quarter.
BUY
2026-05-01 SECtraded 2026-04-30
10
$179
+17.2%
Context
  • 45 earlier Form 4 trades (code P or S) here by this insider (45 buys), the last on Feb 24, 2025.
  • +12.2% median (+10.9% mean) 90-day return after 4 previous buys.
  • The trade is 0.0% of the 32,423 shares held after it.
  • No other insider bought within 30 days.
  • 33 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CFO Lavertu Brandon bought about $179 of ECBK on Apr 30, 2026; 33 funds added in the latest 13F quarter.
BUY
2026-05-01 SECtraded 2026-04-30
10
$178
+17.2%
Context
  • 45 earlier Form 4 trades (code P or S) here by this insider (45 buys), the last on Feb 24, 2025.
  • +12.2% median (+10.9% mean) 90-day return after 4 previous buys.
  • The trade is 0.0% of the 32,393 shares held after it.
  • No other insider bought within 30 days.
  • 33 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CFO Lavertu Brandon bought about $178 of ECBK on Apr 30, 2026; 33 funds added in the latest 13F quarter.
BUY
2026-02-09 SEC
2,200
$40.7K
+17.5%
Context
  • 13 earlier Form 4 trades (code P or S) here by this insider (13 buys), the last on Dec 9, 2025.
  • +2.2% median (+2.2% mean) 90-day return after 2 previous buys.
  • The trade is 38.6% of the 5,700 shares held after it.
  • No other insider bought within 30 days.
  • 33 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Sullivan Maura Ellen bought about $40.7K of ECBK on Feb 9, 2026, the largest insider purchase at the company since 2024; 33 funds added in the latest 13F quarter.
205 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Showing the latest few. to see 200 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
33 funds bought in last quarter
below 87% of Banks
Revenue
+3.6% year over year
below 63% of Banks
Margin
no margin: no revenue reported
Buybacks
$1.0M repurchased, FY to 2026-06-30
below 73% of Banks
Short interest
1.4% of the float short (float per yahoo 2026-10-27) · 11.5 days to cover · settled 2026-10-15
below 69% of Banks
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch ECBK

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+31.0%12M
-6%+7%+21%+34%2025-102025-122026-022026-042026-062026-082026-10 2026-02-09 · Sullivan Maura Ellen bought $40.7K2025-12-08 · Sullivan Maura Ellen bought $11.8K2025-12-08 · Sullivan Maura Ellen bought $8.4K2025-12-08 · Sullivan Maura Ellen bought $8.4K2025-12-09 · Sullivan Maura Ellen bought $6.8K2025-12-08 · Sullivan Maura Ellen bought $6.0K2025-12-08 · Sullivan Maura Ellen bought $5.1K2025-12-08 · Sullivan Maura Ellen bought $3.4K2025-12-09 · Sullivan Maura Ellen bought $1.7K2025-12-08 · Sullivan Maura Ellen bought $1.7K2025-12-08 · Sullivan Maura Ellen bought $1.7K2025-12-08 · Sullivan Maura Ellen bought $1.7K2025-12-08 · Sullivan Maura Ellen bought $1.3K2025-12-09 · Sullivan Maura Ellen bought $1.1K2026-04-30 · Lavertu Brandon bought $1792026-04-30 · Lavertu Brandon bought $1792026-04-30 · Lavertu Brandon bought $1792026-04-30 · Lavertu Brandon bought $178
Insider buy
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns ECBK: institutional holders (13F)

13F holdings, latest reported quarter
$12.6M
418,386 sh
$8.4M
118,853 sh
$2.4M

Congress trades in ECBK

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

ECBK planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

ECBK mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
iShares Micro-Cap ETF
$505.5K position · as of 2026-06-30
0.0%
Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF
$183.9K position · as of 2026-05-31
0.0%
1290 VT Micro Cap Portfolio
$31.5K position · as of 2026-06-30
0.0%
iShares Russell 2000 Value ETF
$1.4M position · as of 2026-06-30
0.0%
Fidelity Small Cap Value Index Fund
$190.0K position · as of 2026-06-30
0.0%
VANGUARD RUSSELL 2000 VALUE INDEX FUND
$105.2K position · as of 2026-05-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 33 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Same sector, ranked by filing activity
Sector by SEC SIC code

ECBK financials

Revenue growth
+3.6%
XBRL, annual
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Free cash flow, TTM
$22.4M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
n/a
no debt line filed
Cash flow to debt
n/a
no debt line filed
Return on equity
+6.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+0.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
P/E, trailing
15.34x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
n/a
no debt line filed
FCF yield
+12.1%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
0.14x
P/E over trailing EPS growth of 112%: four quarters to 2026-06-30 against the four to 2025-06-30
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$598.0K$577.0Kn/an/a
Net income$7.8M$4.0M$4.5M$2.7M
EPS (diluted)0.940.480.520.32
Operating cash flow$9.2M$6.2M$6.4M$7.8M
Buybacks$4.6M$2.7M$2.2Mn/a
SEC XBRL, fiscal years, as known on 2026-10-28

ECBK Stock Sonar score 4/7 axes

Find similar shapesCompare

ECBK ranks highest on risk and compliance (69th percentile) and growth (37th), and lowest on institutional and government (13th), among Banks peers.

Profitability
22
Inputs
  • Return on equity+6.6% · 22 pct, sector of 327
  • Return on assets+0.7% · 22 pct, sector of 334
  • Return on invested capitalfewer than four consecutive quarters of operating income
  • Return on capital employedfewer than four consecutive quarters of operating income
Growth
37
Inputs
  • Revenue growth, YoY+3.6% · 37 pct, sector of 151
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
13
Inputs
  • Funds adding, latest quarter33 · 13 pct, sector of 257
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
69
Inputs
  • Short interest, % of float+1.4% · 69 pct, sector of 374
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Financial health, Insider conviction, US patents
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing